Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
J Biochem Mol Toxicol ; 35(1): e22617, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32864810

ABSTRACT

Diabetes mellitus is a serious worldwide metabolic disease, which is accompanied by hyperglycaemia and affects all organs and body system. Zinc (Zn) is a basic cofactor for many enzymes, which also plays an important role in stabilising the structure of insulin. Liver is the most important target organ after pancreas in diabetic complications. In this study, we aimed to investigate the protective role of Zn in liver damage in streptozotocin (STZ)-induced diabetes mellitus. There are four experimental groups of female Swiss albino rats: group I: control; group II: control + ZnSO4 ; group III: STZ-induced diabetic animals and group IV: STZ-diabetic + ZnSO4 . To induce diabetes, STZ was injected intraperitoneally (65 mg/kg). ZnSO4 (100 mg/kg) was given daily to groups II and IV by gavage for 60 days. At the end of the experiment, rats were killed under anaesthesia and liver tissues were collected. In the diabetic group, hexose, hexosamine, fucose, sialic acid levels, arginase, adenosine deaminase, tissue factor activities and protein carbonyl levels increased, whereas catalase, superoxide dismutase, glutathione-S-transferase, glutathione peroxidase, glutathione reductase and Na+ /K+ -ATPase activities decreased. The administration of Zn to the diabetic group reversed all the negative effects/activities. According to these results, we can suggest that Zn has a protective role against STZ-induced diabetic liver damage.


Subject(s)
Diabetes Complications , Diabetes Mellitus, Experimental , Liver Diseases , Zinc Sulfate/pharmacology , Animals , Diabetes Complications/metabolism , Diabetes Complications/pathology , Diabetes Complications/prevention & control , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Experimental/prevention & control , Female , Liver Diseases/etiology , Liver Diseases/metabolism , Liver Diseases/pathology , Liver Diseases/prevention & control , Rats , Zinc/pharmacology
2.
Biol Trace Elem Res ; 199(6): 2259-2265, 2021 Jun.
Article in English | MEDLINE | ID: mdl-32820429

ABSTRACT

The stomach is among the organs grossly affected organ by diabetic complications. The present study was aimed at investigating the protective role of zinc on stomach of streptozotocin (STZ)-induced diabetes mellitus. Female Swiss albino rats were divided in four experimental groups: Group I, control; group II, control + zinc sulfate; group III, STZ-induced diabetic animals; and group IV, STZ-diabetic + zinc sulfate. Diabetes was induced by intraperitoneal injection of STZ, at a dose of 65 mg/kg body weight. Zinc sulfate (100 mg/kg body weight) was given daily by gavage for 60 days to groups II and IV. At the end of the experiment, the rats were sacrificed, and the tissues were taken. In the diabetic group, hexose, hexosamine, fucose, and sialic acid levels, as well as tissue factor, adenosine deaminase, carbonic anhydrase, xanthine oxidase, lactate dehydrogenase, prolidase activities, advanced oxidized protein products, homocysteine, and TNF-α levels were increased in the stomach tissue homogenates. Whereas, catalase, superoxide dismutase, glutathione-S-transferase, glutathione peroxidase, glutathione reductase, paraoxonase, and aryl esterase activities were decreased in the diabetic group. The administration of zinc reversed all the deformities. These findings suggest that zinc has protective role in ameliorating several mechanisms of STZ-induced diabetic stomach injury.


Subject(s)
Diabetes Mellitus, Experimental , Animals , Antioxidants , Blood Glucose , Diabetes Mellitus, Experimental/drug therapy , Dietary Supplements , Female , Oxidative Stress , Rats , Stomach , Zinc , Zinc Sulfate/pharmacology
3.
Asian Pac J Cancer Prev ; 21(1): 99-106, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-31983171

ABSTRACT

BACKGROUND: The effect of Aloctin, a lectin purified from Aloe vera leaves, and aloe emodin an anthraquinone glycoside purified from the leaves of the same plant, on several cancer cell lines was investigated. METHODS: Aloctin was isolated from A. vera leaf skin by ammonium sulphate precipitation and CNBr-Sepharose 4B-ovalbumin affinity chromatography. Specific new ligands for Aloctin were detected as fetuin and avidin by hemagglutination inhibition tests. The cytotoxic effect of Aloctin and aloe emodin on various human cancer cell lines was tested using MTT assay. Imatinib was tested as standard positive control. The mechanism underlying was tested by the Annexin V-FITC/PI test, with flow cytometry. RESULTS: The most sensitive cells to Aloctin and aloe emodin treatment, were identified as AGS human gastric adenocarcinoma cells. The effect was concentration dependent. It was shown that this effect does not occur by apoptosis or necrosis. In Aloctin-imatinib combinations studies, Aloctin significantly increased the cytotoxic effect of imatinib in a dose-dependent manner. It is expected that the results of this study will reveal important findings for the future use of A. vera lectin as well as aloe emodin in cancer research and contribution to lectin biochemistry.
.


Subject(s)
Aloe/chemistry , Anthraquinones/pharmacology , Antineoplastic Agents/pharmacology , Lectins/pharmacology , Plant Extracts/pharmacology , Stomach Neoplasms/drug therapy , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Humans , Plant Leaves/chemistry
4.
Biometals ; 29(2): 239-48, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26817646

ABSTRACT

Zinc (Zn) is a component of numerous enzymes that function in a wide range of biological process, including growth, development, immunity and intermediary metabolism. Zn may play a role in chronic states such as cardiovascular disease and diabetes mellitus. Zn acts as cofactor and for many enzymes and proteins and has antioxidant, antiinflammatory and antiapoptotic effects. Taking into consideration that lung is a possible target organ for diabetic complications, the aim of this study was to investigate the protective role of zinc on the glycoprotein content and antioxidant enzyme activities of streptozotocin (STZ) induced diabetic rat tissues. Female Swiss albino rats were divided into four groups. Group I, control; Group II, control + zinc sulfate; Group III, STZ-diabetic; Group IV, diabetic + zinc sulfate. Diabetes was induced by intraperitoneal injection of STZ (65 mg/kg body weight). Zinc sulfate was given daily by gavage at a dose of 100 mg/kg body weight every day for 60 days to groups II and IV. At the last day of the experiment, rats were sacrificed, lung tissues were taken. Also, glycoprotein components, tissue factor (TF) activity, protein carbonyl (PC), advanced oxidative protein products (AOPP), hydroxyproline, and enzyme activities in lung tissues were determined. Glycoprotein components, TF activity, lipid peroxidation, non enzymatic glycation, PC, AOPP, hydroxyl proline, lactate dehydrogenase, catalase, superoxide dismutase, myeloperoxidase, xanthine oxidase, adenosine deaminase and prolidase significantly increased in lung tissues of diabetic rats. Also, glutathione levels, paraoxonase, arylesterase, carbonic anhydrase, and Na(+)/K(+)- ATPase activities were decreased. Administration of zinc significantly reversed these effects. Thus, the study indicates that zinc possesses a significantly beneficial effect on the glycoprotein components and oxidant/antioxidant enzyme activities.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Lung/pathology , Oxidative Stress , Zinc Sulfate/administration & dosage , Animals , Aryldialkylphosphatase/metabolism , Carbonic Anhydrases/metabolism , Catalase/metabolism , Diabetes Mellitus, Experimental/blood , Dietary Supplements , Female , Glutathione Peroxidase/metabolism , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation , Lung/drug effects , Lung/enzymology , Peroxidase/metabolism , Rats , Sodium-Potassium-Exchanging ATPase/metabolism , Streptozocin , Superoxide Dismutase/metabolism
5.
Indian J Pharmacol ; 46(3): 322-7, 2014.
Article in English | MEDLINE | ID: mdl-24987181

ABSTRACT

OBJECTIVES: The aim of this study was to investigate the antibacterial, anti-inflammatory, and antioxidant activities and probable toxic effects of Aloe vera (AV) in a rat peritonitis model. MATERIALS AND METHODS: RATS WERE DIVIDED INTO FIVE GROUPS: (1) Control group, (2) AV group, (3) peritonitis group (P), (4) peritonitis + AV group (P + AV), and (5) peritonitis + antibiotherapy group (P + Ab). Ultrafiltration (UF) rates were determined and colony and leukocyte counts were calculated in the dialysate. Glucose, blood urea nitrogen (BUN), creatinine levels, and alanine transaminase (ALT) activities were studied in blood. Glucose, interleukins (IL-1ß, IL-6), and prostaglandin E2 (PGE2) were studied in dialysate and peritoneal tissue for the assessment of the anti-inflammatory effect. Copper/zinc superoxide dismutase (Cu, Zn-SOD), malondialdehyde (MDA), and nitric oxide (NO) were also investigated in peritoneal tissue. RESULTS: Aloe vera increased the UF rate and lowered leukocyte numbers in the peritonitis group. There was no significant difference in blood and dialysate glucose, BUN, creatinine levels and ALT activity among control and AV groups. AV decreased IL-1ß, IL-6 and PGE2 in peritonitis, showing good anti-inflammatory effect. AV showed antioxidant effect on the chosen antioxidant parameters Cu, Zn-SOD, MDA, and NO. CONCLUSION: It was concluded that, AV might be used in peritonitis for its probable UF increasing, anti-inflammatory, and antioxidant effects.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Peritonitis/drug therapy , Plant Preparations/therapeutic use , Staphylococcal Infections/drug therapy , Aloe , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Bacterial Load , Dialysis Solutions/metabolism , Dinoprostone/metabolism , Disease Models, Animal , Gels , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Leukocyte Count , Liver/drug effects , Liver/pathology , Male , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Peritoneum/metabolism , Peritonitis/metabolism , Peritonitis/pathology , Plant Leaves , Plant Preparations/pharmacology , Rats, Wistar , Staphylococcal Infections/metabolism , Staphylococcal Infections/pathology , Staphylococcus aureus/isolation & purification , Superoxide Dismutase/metabolism
6.
Bosn J Basic Med Sci ; 14(2): 105-9, 2014 05.
Article in English | MEDLINE | ID: mdl-24856383

ABSTRACT

Between their broad spectrum of action, vanadium compounds are shown to have insulin mimetic/enhancing effects. Increasing evidence in experimental and clinical studies suggests that oxidative stress plays a major role in the pathogenesis of diabetes and on the onset of diabetic complications. Thus, preventive therapy can alleviate the possible side effects of the disease. The aim of the present study was to investigate the effect of vanadyl sulfate supplementation on the antioxidant system in the stomach tissue of diabetic rats. Male Swiss albino rats were randomly divided into 4 groups: control; control+vanadyl sulfate; diabetic; diabetic+vanadyl sulfate. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ; 65 mg/kg body weight). Vanadyl sulfate (100 mg/kg body weight) was given daily by gavage for 60 days. At the last day of the experiment, stomach tissues were taken and homogenized to make a 10% (w/v) homogenate. Catalase (CAT), superoxide dismutase (SOD), glutathione reductase (GR), glutathione peroxidase (GPx), glutathione-S-transferase (GST), myeloperoxidase (MPO), carbonic anhydrase (CA), glucose-6-phosphate dehydrogenase (G6PD) and lactate dehydrogenase (LDH) activities were determined in the stomach tissue. CAT, SOD, GR, GPx, GST, CA, G6PD and LDH activities were increased in diabetic rats when compared to normal rats. Vanadium treatment significantly reduced the elevated activities of GR, GPx, GST compared with the diabetic group whereas the decreases in CAT, SOD, CA, G6PD and LDH activities were insignificant. No significant change was seen for MPO activity between the groups. It was concluded that vanadium could be used for its ameliorative effect against oxidative stress in diabetes.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Hypoglycemic Agents/pharmacology , Oxidative Stress/drug effects , Stomach/drug effects , Vanadium Compounds/pharmacology , Administration, Oral , Animals , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Male , Oxidoreductases/metabolism , Rats , Stomach/enzymology , Vanadium Compounds/therapeutic use
7.
Biometals ; 24(5): 943-9, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21479831

ABSTRACT

In recent years, the role of free radical damage consequent to oxidative stress is widely discussed in diabetic complications. In this aspect, the protection of cell integrity by trace elements is a topic to be investigated. Vanadium is a trace element believed to be important for normal cell function and development. The aim of the present study was to investigate the effect of vanadyl sulfate supplementation on the antioxidant system in the muscle tissue of diabetic rats. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ, 65 mg/kg body weight) to male Swiss albino rats. The rats were randomly divided into 4 groups: Group I, control; Group II, vanadyl sulfate control; Group III, STZ-diabetic untreated; Group IV, STZ-diabetic treated with vanadyl sulfate. Vanadyl sulfate (100 mg/kg) was given daily by gavage for 60 days. At the last day of the experiment, rats were killed, muscle tissues were taken, homogenized in cold saline to make a 10% (w/v) homogenate. Body weights and blood glucose levels were estimated at 0, 30 and 60th days. Antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx), glutathione-S-transferase (GST), as well as carbonic anhydrase (CA), myeloperoxidase (MPO) activities and protein carbonyl content (PCC) were determined in muscle tissue. Vanadyl sulfate administration improved the loss in body weight due to STZ-induced diabetes and decreased the rise in blood glucose levels. It was shown that vanadium supplementation to diabetic rats significantly decrease serum antioxidant enzyme levels, which were significantly raised by diabetes in muscle tissue showing that this trace element could be used as preventive for diabetic complications.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Dietary Supplements , Muscle, Skeletal/drug effects , Oxidative Stress/drug effects , Vanadium Compounds/administration & dosage , Animals , Antioxidants/metabolism , Blood Glucose/analysis , Body Weight/drug effects , Diabetes Mellitus, Experimental/chemically induced , Male , Muscle, Skeletal/metabolism , Rats , Streptozocin , Vanadium Compounds/pharmacology
8.
Cancer Genet Cytogenet ; 189(1): 1-4, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19167605

ABSTRACT

Manganese superoxide dismutase (MnSOD) is one of the major enzymes responsible for the defense against oxidative damage due to reactive oxygen species (ROS) in the mitochondria. C-->T substitution in the MnSOD gene (SOD2) produces an Ala-->Val change at amino acid 16, in the mitochondrial targeting sequence of the MnSOD precursor. This seems to reduce transport of the enzyme into mitochondria, decreasing its defense capacity against oxidative stress. The present case-control study was conducted to investigate the association of SOD2 genetic polymorphism with individual susceptibility to lung cancer. Ala16Val polymorphisms were determined using polymerase chain reaction, restriction fragment length polymorphism mapping, and agarose gel electrophoresis techniques in 100 lung cancer patients and 50 healthy control subjects. The frequency of the Val allele (OR=1.297, 95% CI=1.095-1.536) and the Val/Val genotype (OR=7.00, 95% CI=2.282-21.476) was significantly higher in lung cancer patients than in control subjects. There was a combined effect of Val/Val genotype as a genetic factor with smoking as an environment factor (OR=2.24). The increase in risk of lung cancer was lesser with this combined effect than with the Val/Val genotype alone. Thus, the Val/Val genotype of SOD2 may be associated with lung cancer in a Turkish population.


Subject(s)
Lung Neoplasms/genetics , Polymorphism, Genetic , Superoxide Dismutase/genetics , Case-Control Studies , Genetic Predisposition to Disease , Genotype , Humans , Oxidative Stress/genetics , Risk Factors , Turkey , Valine/genetics , Valine/metabolism
9.
Oxid Med Cell Longev ; 2(2): 99-106, 2009.
Article in English | MEDLINE | ID: mdl-20357932

ABSTRACT

In order to demonstrate whether the known biological effects of Aloe vera (L.) Burm. fil. could correlate with the antioxidant activity of the plant, the antioxidant activity of the aqueous leaf extract was investigated. The present study demonstrated that the aqueous extract from A. vera leaves contained naturally occuring antioxidant components, including total phenols, flavonoids, ascorbic acid, beta-carotene and alpha-tocopherol. The extract exhibited inhibitory capacity against Fe(3+)/ascorbic acid induced phosphatidylcholine liposome oxidation, scavenged stable DPPH(*), ABTS(*+) and superoxide anion radicals, and acted as reductant. In contrast, the leaf inner gel did not show any antioxidant activity. It was concluded that the known beneficial effects of Aloe vera could be attributed to its antioxidant activity and could be related to the presence of phenolic compounds and antioxidant vitamins.


Subject(s)
Aloe/chemistry , Antioxidants/pharmacology , Plant Extracts/pharmacology , Ascorbic Acid/therapeutic use , Benzothiazoles/chemistry , Biphenyl Compounds/chemistry , Flavonoids/therapeutic use , Free Radical Scavengers/therapeutic use , Humans , Lipid Peroxidation/drug effects , Neurodegenerative Diseases/drug therapy , Phenols/pharmacology , Picrates/chemistry , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Sulfonic Acids/chemistry , Superoxides/chemistry , beta Carotene/therapeutic use , beta-Tocopherol/therapeutic use
10.
Med Sci Monit ; 14(8): BR165-73, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18667993

ABSTRACT

BACKGROUND: The significant roles of telomerase in carcinogenesis and drug resistance have attracted growing attention as potential therapies. The aim of the study was to investigate the effect of suramin on the telomerase activity of C6 glioma cells and on the growth of C6 glioma spheroids. MATERIAL/METHODS: C6 rat glioma cells were treated with suramin at doses of 175 and 250 microM, and also with an increasing dosage for 96 hours. The effect of suramin on monolayer and spheroid cultures was determined by evaluating cell proliferation, spheroid growth, bromodeoxyuridine labeling index, changes of spheroid ultrastructure, and telomerase activity. RESULTS: Suramin inhibited telomerase activity in a dose-dependent manner. Suramin at 250 microM and 175 microM reduced telomerase activity and cell proliferation, spheroid growth, and bromodeoxyuridine labeling index. These groups commonly revealed distorted nuclei (i.e., nucleolus segregation at 250 microM, many vacuoles, vacuole fusions, and smoothing of the cell surface). Contrary to the effects of individually applied suramin, the increased dose of suramin increased telomerase activity but inhibited cell proliferation and bromodeoxyuridine labeling index only at the 24th and 96th hours; it inhibited spheroid growth at the 96th hour. The increased dose of the suramin-treated group showed changes of spheroid ultrastructure similar to those of the control group except for rarely observed vacuoles or vacuole fusion and microvilli. CONCLUSIONS: To the best of our knowledge, this is the first study in the English language to show in vitro cytotoxic effect of suramin via telomerase inhibition on C6 glioma cells and spheroids.


Subject(s)
Glioma/enzymology , Glioma/pathology , Spheroids, Cellular/drug effects , Spheroids, Cellular/pathology , Suramin/pharmacology , Telomerase/antagonists & inhibitors , Animals , Bromodeoxyuridine/metabolism , Cell Cycle/drug effects , Cell Nucleolus/drug effects , Cell Nucleolus/ultrastructure , Cell Proliferation/drug effects , DNA, Neoplasm/biosynthesis , Rats , Spheroids, Cellular/enzymology , Spheroids, Cellular/ultrastructure , Time Factors , Tumor Cells, Cultured
11.
Phytother Res ; 21(11): 1070-5, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17685385

ABSTRACT

In this study, the prophylactic effect of the main lectin present in Aloe vera leaf pulp extract (Aloctin I) was assayed against Ehrlich ascites tumours in mice. The lectin administered prophylactically before tumour implantation regressed tumour size, however, this activity was less potent than that of the A. vera leaf pulp extract previously shown in our laboratory. Accordingly, serum sialic acid and tumour necrosis factor alpha (TNFalpha) levels, chosen as tumour markers, were decreased significantly by the prophylactic administration of the lectin. The increase in spleen and thymus weights in the group given only Aloctin I, could be explained by the immunomodulatory and mitogenic effects of lectins. These findings, along with lymphoid hyperplasia observed in spleen and thymus, suggest that the tumour preventive effect of Aloctin I could be due to its immunomodulatory activity.


Subject(s)
Aloe/chemistry , Carcinoma, Ehrlich Tumor/prevention & control , Plant Leaves/chemistry , Plant Lectins/therapeutic use , Animals , Carcinoma, Ehrlich Tumor/blood , Carcinoma, Ehrlich Tumor/pathology , Leukocyte Count , Male , Mice , N-Acetylneuraminic Acid/blood , Organ Size/drug effects , Plant Lectins/isolation & purification , Plant Lectins/pharmacology , Spleen/drug effects , Spleen/pathology , Thymus Gland/drug effects , Thymus Gland/pathology , Tumor Necrosis Factor-alpha/blood
12.
Eur J Cancer Prev ; 16(2): 151-7, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17297391

ABSTRACT

Among the various known therapeutic effects of Aloe vera (L.) Burm. fil., a few recent studies have shown that preparations of the plant leaves can prevent or regress the growth of certain tumours. In this study, undertaken with A. vera leaf pulp extract against Ehrlich ascites tumours in mice, the animals were separated into five groups: I - healthy control, II - tumour control, III - experiment 1 (extract given before tumour inoculation), IV - experiment 2 (extract given with tumour inoculation) and V - experiment 3 (extract given after tumour inoculation). Ehrlich ascites tumours (0.33 ml) were injected subcutaneously into groups II-V. Aloe extract was injected at 55 mg protein/kg, twice a week for 21 days. Tumour size, thymus and spleen weights were measured, as well as leucocyte count, tumour necrosis factor-alpha and sialic acid as tumour markers. The best inhibitory effect on tumour growth was obtained with the extract given prophylactically before tumour implantation (experiment 1), although Aloe extract also regressed tumour sizes when given simultaneously with (experiment 2), or therapeutically after (experiment 3), tumour implantation. Accordingly, serum sialic acid and tumour necrosis factor-alpha levels, chosen as tumour markers, which were raised in the tumour control group, were significantly decreased by the prophylactic administration of the extract. The increase in leucocyte count seen in experiment 1 and 2 groups, along with lymphoid hyperplasia observed in spleen and thymus necroscopy, lead us to think that the tumour preventive effect of Aloe could be due to its immunomodulatory activity. According to our results, A. vera could be proposed as a prophylactic for cancer prevention.


Subject(s)
Aloe , Carcinoma, Ehrlich Tumor/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Plant Leaves , Animals , Male , Mice
13.
Int J Biomed Sci ; 3(2): 104-11, 2007 Jun.
Article in English | MEDLINE | ID: mdl-23675031

ABSTRACT

Glioblastoma multiforme (GBM) is the most treatment-resistant glioma variant. Significant roles for telomerase in etiology, recurrence and drug resistance of GBM have been highlighted. Suramin (Bayer, Leverkusen, Germany) is an antineoplastic agent that affects many cellular mechanisms including growth factor, purinergic receptor, cytokine and key cellular enzymes signaling. The aim of this study was to investigate whether suramin, 40 mg/kg, i.p., inhibits telomerase activity in a subcutaneous C6 glioma/Wistar experimental brain tumor model using PCR based telomeric repeat amplification assay. In comparison to the control group, suramin increased tumor volume and telomerase activity. We also used transmission electron microscopy to evaluate the alterations of cell morphology. Apoptosis was seen markedly in electron micrographs of the control group and anti-apoptotic activity of telomerase was verified in the electron micrographs of suramin-applied group. The in vitro inhibitory effects of suramin on telomerase activity in several cell lines except for brain tumors have been reported. Contrary to in vitro reports, our results were the first to demonstrate that suramin increased telomerase activity in a C6 glioma/Wistar experimental brain tumor. Large numbers of drugs exhibited apparent hormetic effects on cultured cancer cells and in vivo cancer growth. Several drug examples for their hormetic effects in vivo were listed as resveratrol, suramin, and tamoxifen. The action of suramin in the present study could be evaluated as one of the hormetic examples of suramin in vivo.

14.
Indian J Exp Biol ; 42(1): 48-52, 2004 Jan.
Article in English | MEDLINE | ID: mdl-15274480

ABSTRACT

Significant degenerative changes were observed in the kidney tissue of untreated neonatal streptozotocin (n0STZ)-induced type-II diabetic rats. These degenerative changes were diminished in the kidney tissue of diabetic animals given glibenclamide and Aloe leaf gel and pulp extracts. Kidney lipid peroxidation levels were increased in diabetic rats compared to healthy rats; these levels were higher in rats treated with glibenclamide than in those which received Aloe extracts. Serum urea and creatinine levels were higher in diabetic rats in comparison to healthy rats. The administration of Aloe gel extract and glibenclamide decreased serum urea and creatinine levels in comparison to diabetic controls. Only A. vera leaf gel extract showed improvement both in histological and biochemical parameters suggesting a protective effect of A. vera on mild damage caused by type-II diabetes on kidney tissue.


Subject(s)
Aloe/metabolism , Diabetes Mellitus, Experimental/drug therapy , Kidney/drug effects , Plant Extracts/pharmacology , Plant Leaves/metabolism , Animals , Creatinine/metabolism , Kidney/metabolism , Kidney/pathology , Lipid Peroxidation , Rats , Rats, Wistar , Urea/metabolism
15.
Biol Pharm Bull ; 27(5): 694-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15133247

ABSTRACT

The aim of this work was to investigate the effects of Aloe vera leaf pulp and gel extracts on the liver tissue of neonatal streptozotocin (n0STZ)-induced type-II diabetic rats. The diabetic rats were separated into four groups and each group was given the following samples by gavage, daily for 15 d: phosphate buffered saline (PBS; diabetic control), Aloe leaf pulp extract, Aloe leaf gel extract, glibenclamide. Liver tissues were examined histologically. The markers of oxidative stress: glutathione (GSH), non-enzymatic glycosylation (NEG) and lipid peroxidation (LPO), were determined in liver tissue. Biochemical parameters for liver function: serum alkaline phosphatase (ALP), and alanine transaminase (ALP) activities, were evaluated. All parameters were also determined in healthy (non diabetic) rats for comparison. In the diabetic control group, the degenerative changes in liver tissue were remarkable, while in the diabetic groups given Aloe pulp and gel extracts and glibenclamide, the damage to the liver tissue was decreased. The increase of GSH and the decrease of NEG and LPO in liver tissues with the treatment of Aloe gel extract, is consistent with the beneficial effect of Aloe. Serum ALP and ALT activities were also decreased in the groups given Aloe gel extract. It was concluded that Aloe gel extract has a protective effect comparable to glibenclamide against hepatotoxicity produced by diabetes if used in the treatment of type-II diabetes.


Subject(s)
Aloe , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Liver/drug effects , Animals , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 2/pathology , Gels , Liver/pathology , Phytotherapy/methods , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Leaves , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...